Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

MoonLake Immunotherapeutics (MLTX) sees significant social media buzz and price action driven by buyout speculation and short squeeze potential, despite recent negative clinical trial results. Recent posts highlight institutional buying and positive outlooks on FDA approval.

### About MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics is a biotechnology company focused on developing and commercializing novel immunotherapies.  
MoonLake Immunotherapeutics Class A Ordinary Shares uses the ticker $MLTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) trading volume is up XXXXXX% from the previous week.
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) engagements is up XXXX% from the previous week.
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) posts created is up XXXXXX% from the previous week.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/close.tsv)  
The current price surge is attributed to speculation of a potential buyout or short squeeze, coupled with a successful stock offering. Recent social posts indicate institutional buying and positive outlooks on FDA approval, which are currently outweighing negative clinical trial results.  

24-Hour: XXXX%
7-Day: XXXXX%
30-Day: XXXXX%

1-Year High: $XX on 2025-09-26  
1-Year Low: $XXXX on 2025-09-29  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/alt_rank.tsv)  
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is currently AltRank #1,250 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXXXX -XXX  
X Month: XXXXX -XX  
X Months: XXXXX +705  
X Year: XXXXX -X  
1-Year High: XXXXX on 2025-03-08  
1-Year Low: XX on 2025-09-29  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -XX  
X Month: XX -XX  
X Months: XX -XX  
X Year: XX -XX  
1-Year High: XX on 2025-04-21  
1-Year Low: XX on 2025-01-08  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX +98%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX +174%  
X Year: XXXXXXXXX +122%  
1-Year High: XXXXXXX on 2025-09-29  
1-Year Low: XXX on 2025-04-18  

Engagements by network (24h):
News: XX
Reddit: XXX
X: XXXXX
YouTube: XX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +38%  
X Months: XXXXX +119%  
X Year: XXXXX +137%  
1-Year High: XXX on 2025-09-29  
1-Year Low: XX on 2025-01-27  

Mentions by network (24h):
News: X
Reddit: XX
X: XXX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +29%  
X Months: XXXXX +166%  
X Year: XXXXX +203%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-04-19  

The most influential creators that mention MoonLake Immunotherapeutics Class A Ordinary Shares in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)         | X    | XXXXX     | X     | XXX         |
| [@SMALLCAPSAXIS](/creator/twitter/SMALLCAPSAXIS)   | X    | XXX       | X     | XXX         |
| [@Twills08](/creator/twitter/Twills08)             | X    | XXX       | X     | XXX         |
| [@Biotekster](/creator/twitter/Biotekster)         | X    | XXX       | X     | XXX         |
| [@FluidBotStocks](/creator/twitter/FluidBotStocks) | X    | XXX       | X     | XX          |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)         | X    | XXXXXX    | X     | XX          |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)       | X    | XXXXXX    | X     | XX          |

[View More](/list/creators/$mltx/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -X%  
1-Year High: XXX% on 2025-01-26  
1-Year Low: XX% on 2024-12-20  

Most Supportive Themes:
- Potential Buyout/Merger: (35%) Speculation about a potential buyout by a larger pharmaceutical company, particularly Merck, is a recurring theme, fueled by insider buying activity.
- Positive Technical Analysis/Squeeze Potential: (25%) Some posts highlight potential for a short squeeze, with bullish technical analysis and mentions of institutional buying.
- Focus on Psoriasis Pivot: (15%) Optimism surrounding the company's potential pivot to psoriasis treatment, with some seeing the recent negative data as an opportunity.
  
Most Critical Themes:
- Concerns over Vela Phase X Study: (50%) The primary critical theme revolves around the failure of the sonelokimab drug to meet primary endpoints in the Vela phase X study for hidradenitis suppurativa.
- Negative Data and Regulatory Pathway Uncertainty: (30%) Analysts are questioning the regulatory pathway and potential approval of the drug after it failed to meet primary endpoints.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%  
X Month: XXXXX% -XXXXX%  
X Months: XXXXX% +0.002%  
X Year: XXXXX% -XXXXX%  
1-Year High: XXXX% on 2025-09-29  
1-Year Low: XXXXXX% on 2025-02-27  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2024-12-28  
1-Year Low: XXXXXXX% on 2025-12-10  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$7.50%  
X Month: $XXXXXXXXXXXXX +$34%  
X Months: $XXXXXXXXXXXXX -$63%  
X Year: $XXXXXXXXXXXXX -$70%  
1-Year High: $XXXXXXXXXXXXX on 2025-09-26  
1-Year Low: $XXXXXXXXXXX on 2025-09-29  

### Top MoonLake Immunotherapeutics Class A Ordinary Shares News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Institutional Holdings Nasdaq"  
[News Link](https://www.nasdaq.com/market-activity/stocks/mltx/institutional-holdings) [@Nasdaq](/creator/x/Nasdaq) 2025-12-06T04:57Z 165.8K followers, XXX engagements



### Top MoonLake Immunotherapeutics Class A Ordinary Shares Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Shorts will get crushed $KULR $KVUE $LAES $LASE $LFIN $LFLY $LGHL $LIDR $LILM $LMDX $LSTA $LTRY $LYT $MAC $MANH $MAPS $MARPS $MBRX $MCAC $MCLD $MCOM $MCRB $MEOA $METX $MFA $MGIH $MGNX $MICT $MIGI $MKFG $MLGO $MLTX $MMAT $MMV $MNTS $MOB $MOGO $MOTS $MOV $MRIN $MRKR $MRM"  
[X Link](https://x.com/SMALLCAPSAXIS/status/1998428725629587844) [@SMALLCAPSAXIS](/creator/x/SMALLCAPSAXIS) 2025-12-09T16:25Z XXX followers, XXX engagements


"🔔 Markets open: Futures +0.1% amid Fed cut odds (87% Wed)S&P eyes 6900 yields XXXX% cap joy. $NVDA +2% on China H200 nod $GME pre-earnings🚀 (WSB YOLO calls). Reddit hypes $RIVN turnaround (+$2.4M bet) $MLTX run (+10% data leak). AZO/ AVAV reports: Auto boom vs. risk-off fade $BTC $90K flat. #FedWeek #MarketOpen"  
[X Link](https://x.com/TessT399016/status/1998400998252114185) [@TessT399016](/creator/x/TessT399016) 2025-12-09T14:35Z XXX followers, XXX engagements


"- They also hold silver as a hedge but favor $MLTXs growth opportunity more. - Warning: $MLTX is small-cap and risky; options are illiquid with wide spreadsinvest only what you can afford to lose"  
[X Link](https://x.com/FluidBotStocks/status/1998218008930509232) [@FluidBotStocks](/creator/x/FluidBotStocks) 2025-12-09T02:27Z XXX followers, XXX engagements


"- The author holds long-term stock and also some December 2025 call options as a lottery ticket for big gains aware of high timing risks and low option liquidity. - The poster shares personal struggles for transparency but remains confident $MLTX will provide financial gains"  
[X Link](https://x.com/FluidBotStocks/status/1998218008091582614) [@FluidBotStocks](/creator/x/FluidBotStocks) 2025-12-09T02:27Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

MoonLake Immunotherapeutics (MLTX) sees significant social media buzz and price action driven by buyout speculation and short squeeze potential, despite recent negative clinical trial results. Recent posts highlight institutional buying and positive outlooks on FDA approval.

About MoonLake Immunotherapeutics Class A Ordinary Shares

MoonLake Immunotherapeutics is a biotechnology company focused on developing and commercializing novel immunotherapies.
MoonLake Immunotherapeutics Class A Ordinary Shares uses the ticker $MLTX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) trading volume is up XXXXXX% from the previous week.
  • MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) engagements is up XXXX% from the previous week.
  • MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) posts created is up XXXXXX% from the previous week.

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The current price surge is attributed to speculation of a potential buyout or short squeeze, coupled with a successful stock offering. Recent social posts indicate institutional buying and positive outlooks on FDA approval, which are currently outweighing negative clinical trial results.

24-Hour: XXXX% 7-Day: XXXXX% 30-Day: XXXXX%

1-Year High: $XX on 2025-09-26
1-Year Low: $XXXX on 2025-09-29

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is currently AltRank #1,250 based on combined combined social and market metrics Daily Average: XXX
X Week: XXXXX -XXX
X Month: XXXXX -XX
X Months: XXXXX +705
X Year: XXXXX -X
1-Year High: XXXXX on 2025-03-08
1-Year Low: XX on 2025-09-29

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-04-21
1-Year Low: XX on 2025-01-08

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX +98%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +174%
X Year: XXXXXXXXX +122%
1-Year High: XXXXXXX on 2025-09-29
1-Year Low: XXX on 2025-04-18

Engagements by network (24h): News: XX Reddit: XXX X: XXXXX YouTube: XX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +38%
X Months: XXXXX +119%
X Year: XXXXX +137%
1-Year High: XXX on 2025-09-29
1-Year Low: XX on 2025-01-27

Mentions by network (24h): News: X Reddit: XX X: XXX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -XX%
X Month: XXX +29%
X Months: XXXXX +166%
X Year: XXXXX +203%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-19

The most influential creators that mention MoonLake Immunotherapeutics Class A Ordinary Shares in the last XX hours

Creator Rank Followers Posts Engagements
@Andre_AGTC X XXXXX X XXX
@SMALLCAPSAXIS X XXX X XXX
@Twills08 X XXX X XXX
@Biotekster X XXX X XXX
@FluidBotStocks X XXX X XX
@BiopharmIQ X XXXXXX X XX
@RNAiAnalyst X XXXXXX X XX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -X%
1-Year High: XXX% on 2025-01-26
1-Year Low: XX% on 2024-12-20

Most Supportive Themes:

  • Potential Buyout/Merger: (35%) Speculation about a potential buyout by a larger pharmaceutical company, particularly Merck, is a recurring theme, fueled by insider buying activity.
  • Positive Technical Analysis/Squeeze Potential: (25%) Some posts highlight potential for a short squeeze, with bullish technical analysis and mentions of institutional buying.
  • Focus on Psoriasis Pivot: (15%) Optimism surrounding the company's potential pivot to psoriasis treatment, with some seeing the recent negative data as an opportunity.

Most Critical Themes:

  • Concerns over Vela Phase X Study: (50%) The primary critical theme revolves around the failure of the sonelokimab drug to meet primary endpoints in the Vela phase X study for hidradenitis suppurativa.
  • Negative Data and Regulatory Pathway Uncertainty: (30%) Analysts are questioning the regulatory pathway and potential approval of the drug after it failed to meet primary endpoints.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
X Month: XXXXX% -XXXXX%
X Months: XXXXX% +0.002%
X Year: XXXXX% -XXXXX%
1-Year High: XXXX% on 2025-09-29
1-Year Low: XXXXXX% on 2025-02-27

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-12-28
1-Year Low: XXXXXXX% on 2025-12-10

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$7.50%
X Month: $XXXXXXXXXXXXX +$34%
X Months: $XXXXXXXXXXXXX -$63%
X Year: $XXXXXXXXXXXXX -$70%
1-Year High: $XXXXXXXXXXXXX on 2025-09-26
1-Year Low: $XXXXXXXXXXX on 2025-09-29

Top MoonLake Immunotherapeutics Class A Ordinary Shares News

Top news links shared on social in the last XX hours

Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.

"MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Institutional Holdings Nasdaq"
News Link @Nasdaq 2025-12-06T04:57Z 165.8K followers, XXX engagements

Top MoonLake Immunotherapeutics Class A Ordinary Shares Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Shorts will get crushed $KULR $KVUE $LAES $LASE $LFIN $LFLY $LGHL $LIDR $LILM $LMDX $LSTA $LTRY $LYT $MAC $MANH $MAPS $MARPS $MBRX $MCAC $MCLD $MCOM $MCRB $MEOA $METX $MFA $MGIH $MGNX $MICT $MIGI $MKFG $MLGO $MLTX $MMAT $MMV $MNTS $MOB $MOGO $MOTS $MOV $MRIN $MRKR $MRM"
X Link @SMALLCAPSAXIS 2025-12-09T16:25Z XXX followers, XXX engagements

"🔔 Markets open: Futures +0.1% amid Fed cut odds (87% Wed)S&P eyes 6900 yields XXXX% cap joy. $NVDA +2% on China H200 nod $GME pre-earnings🚀 (WSB YOLO calls). Reddit hypes $RIVN turnaround (+$2.4M bet) $MLTX run (+10% data leak). AZO/ AVAV reports: Auto boom vs. risk-off fade $BTC $90K flat. #FedWeek #MarketOpen"
X Link @TessT399016 2025-12-09T14:35Z XXX followers, XXX engagements

"- They also hold silver as a hedge but favor $MLTXs growth opportunity more. - Warning: $MLTX is small-cap and risky; options are illiquid with wide spreadsinvest only what you can afford to lose"
X Link @FluidBotStocks 2025-12-09T02:27Z XXX followers, XXX engagements

"- The author holds long-term stock and also some December 2025 call options as a lottery ticket for big gains aware of high timing risks and low option liquidity. - The poster shares personal struggles for transparency but remains confident $MLTX will provide financial gains"
X Link @FluidBotStocks 2025-12-09T02:27Z XXX followers, XXX engagements

MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)
/topic/$mltx